InnovAge Holding Corp has a consensus price target of $8.86 based on the ratings of 10 analysts. The high is $19 issued by Barclays on August 12, 2021. The low is $3.9 issued by Piper Sandler on May 11, 2022. The 3 most-recent analyst ratings were released by JP Morgan, Goldman Sachs, and Goldman Sachs on March 13, 2024, February 8, 2024, and February 15, 2023, respectively. With an average price target of $7.33 between JP Morgan, Goldman Sachs, and Goldman Sachs, there's an implied 20.81% upside for InnovAge Holding Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/13/2024 | Buy Now | -1.15% | JP Morgan | Lisa Gill | $7 → $6 | Maintains | Neutral | Get Alert |
02/08/2024 | Buy Now | 15.32% | Goldman Sachs | Jamie Perse | $8 → $7 | Maintains | Neutral | Get Alert |
02/15/2023 | Buy Now | 48.27% | Goldman Sachs | Jamie Perse | $8 → $9 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | 31.8% | JP Morgan | Lisa Gill | $5 → $8 | Maintains | Neutral | Get Alert |
11/23/2022 | Buy Now | 31.8% | Goldman Sachs | Jamie Perse | $6 → $8 | Maintains | Neutral | Get Alert |
11/16/2022 | Buy Now | 31.8% | Citigroup | Jason Cassorla | $5 → $8 | Maintains | Neutral | Get Alert |
09/15/2022 | Buy Now | -17.63% | Barclays | Sarah James | $6 → $5 | Maintains | Equal-Weight | Get Alert |
05/16/2022 | Buy Now | -17.63% | Baird | Vikram Kesavabhotla | $6 → $5 | Downgrade | Outperform → Neutral | Get Alert |
05/11/2022 | Buy Now | -35.75% | Piper Sandler | Jeff Garro | $5 → $3.9 | Maintains | Underweight | Get Alert |
04/20/2022 | Buy Now | -17.63% | Piper Sandler | Jeff Garro | $4 → $5 | Downgrade | Neutral → Underweight | Get Alert |
12/28/2021 | Buy Now | -34.1% | Goldman Sachs | Jamie Perse | $15 → $4 | Downgrade | Buy → Neutral | Get Alert |
12/27/2021 | Buy Now | 7.08% | Barclays | Sarah James | $22 → $6.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
12/17/2021 | Buy Now | 64.74% | JP Morgan | Lisa Gill | — | Initiates | → Neutral | Get Alert |
09/29/2021 | Buy Now | — | Citigroup | Ralph Giacobbe | — | Downgrade | Buy → Neutral | Get Alert |
09/22/2021 | Buy Now | — | William Blair | Matt Larew | — | Downgrade | Outperform → Market Perform | Get Alert |
09/10/2021 | Buy Now | 180.07% | Cowen & Co. | Gary Taylor | — | Initiates | → Market Perform | Get Alert |
08/12/2021 | Buy Now | 213.01% | Barclays | Steve Valiquette | — | Upgrade | Equal-Weight → Overweight | Get Alert |
The latest price target for InnovAge Holding (NASDAQ:INNV) was reported by JP Morgan on March 13, 2024. The analyst firm set a price target for $6.00 expecting INNV to fall to within 12 months (a possible -1.15% downside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for InnovAge Holding (NASDAQ:INNV) was provided by JP Morgan, and InnovAge Holding maintained their neutral rating.
The last upgrade for InnovAge Holding Corp happened on August 12, 2021 when Barclays raised their price target to $19. Barclays previously had an equal-weight for InnovAge Holding Corp.
The last downgrade for InnovAge Holding Corp happened on May 16, 2022 when Baird changed their price target from $6 to $5 for InnovAge Holding Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InnovAge Holding, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InnovAge Holding was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.
While ratings are subjective and will change, the latest InnovAge Holding (INNV) rating was a maintained with a price target of $7.00 to $6.00. The current price InnovAge Holding (INNV) is trading at is $6.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.